ATE485040T1 - Carbazol-derivate als funktionale 5-ht6-liganden - Google Patents
Carbazol-derivate als funktionale 5-ht6-ligandenInfo
- Publication number
- ATE485040T1 ATE485040T1 AT06766266T AT06766266T ATE485040T1 AT E485040 T1 ATE485040 T1 AT E485040T1 AT 06766266 T AT06766266 T AT 06766266T AT 06766266 T AT06766266 T AT 06766266T AT E485040 T1 ATE485040 T1 AT E485040T1
- Authority
- AT
- Austria
- Prior art keywords
- carbazole derivatives
- receptor
- ligands
- functional
- stereoisomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Anesthesiology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Indole Compounds (AREA)
- Structures Or Materials For Encapsulating Or Coating Semiconductor Devices Or Solid State Devices (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1504CH2005 | 2005-10-19 | ||
PCT/IN2006/000195 WO2007046111A1 (en) | 2005-10-19 | 2006-06-09 | Carbazole derivatives as functional 5-ht6 ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE485040T1 true ATE485040T1 (de) | 2010-11-15 |
Family
ID=37054637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06766266T ATE485040T1 (de) | 2005-10-19 | 2006-06-09 | Carbazol-derivate als funktionale 5-ht6-liganden |
Country Status (24)
Country | Link |
---|---|
US (1) | US8143303B2 (de) |
EP (1) | EP1948166B1 (de) |
JP (1) | JP2009512681A (de) |
KR (1) | KR101125820B1 (de) |
CN (1) | CN101291670B (de) |
AT (1) | ATE485040T1 (de) |
AU (1) | AU2006305502B2 (de) |
BR (1) | BRPI0619308A2 (de) |
CA (1) | CA2626646C (de) |
CY (1) | CY1111560T1 (de) |
DE (1) | DE602006017722D1 (de) |
DK (1) | DK1948166T3 (de) |
EA (1) | EA014694B1 (de) |
ES (1) | ES2354455T3 (de) |
HK (1) | HK1120424A1 (de) |
HR (1) | HRP20110041T1 (de) |
NO (1) | NO341252B1 (de) |
NZ (1) | NZ567865A (de) |
PL (1) | PL1948166T3 (de) |
PT (1) | PT1948166E (de) |
RS (1) | RS51627B (de) |
SI (1) | SI1948166T1 (de) |
WO (1) | WO2007046111A1 (de) |
ZA (1) | ZA200803118B (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2850707C (en) * | 2011-10-03 | 2023-03-21 | The University Of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
CN106045972B (zh) * | 2016-06-03 | 2018-11-16 | 中山大学 | 咔唑-利凡斯的明二联体及其药物组合物和应用 |
CN106749184B (zh) * | 2016-11-15 | 2020-07-17 | 中山大学 | 8-氨基喹啉-羟基咔唑杂联体,其制备方法及其药物组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE319683T1 (de) * | 1998-12-11 | 2006-03-15 | Univ Virginia Commonwealth | Selektive 5-ht 6-rezeptor-liganden |
WO2003030901A1 (en) * | 2001-10-09 | 2003-04-17 | Pharmacia & Upjohn Company | Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands |
-
2006
- 2006-06-09 KR KR1020087010404A patent/KR101125820B1/ko active IP Right Grant
- 2006-06-09 PL PL06766266T patent/PL1948166T3/pl unknown
- 2006-06-09 DE DE602006017722T patent/DE602006017722D1/de active Active
- 2006-06-09 US US12/083,707 patent/US8143303B2/en not_active Expired - Fee Related
- 2006-06-09 RS RS20110017A patent/RS51627B/en unknown
- 2006-06-09 AT AT06766266T patent/ATE485040T1/de active
- 2006-06-09 NZ NZ567865A patent/NZ567865A/en not_active IP Right Cessation
- 2006-06-09 CN CN2006800390082A patent/CN101291670B/zh not_active Expired - Fee Related
- 2006-06-09 JP JP2008536206A patent/JP2009512681A/ja active Pending
- 2006-06-09 BR BRPI0619308-0A patent/BRPI0619308A2/pt not_active Application Discontinuation
- 2006-06-09 EP EP06766266A patent/EP1948166B1/de active Active
- 2006-06-09 PT PT06766266T patent/PT1948166E/pt unknown
- 2006-06-09 WO PCT/IN2006/000195 patent/WO2007046111A1/en active Application Filing
- 2006-06-09 SI SI200630873T patent/SI1948166T1/sl unknown
- 2006-06-09 CA CA2626646A patent/CA2626646C/en not_active Expired - Fee Related
- 2006-06-09 DK DK06766266.8T patent/DK1948166T3/da active
- 2006-06-09 EA EA200801114A patent/EA014694B1/ru not_active IP Right Cessation
- 2006-06-09 AU AU2006305502A patent/AU2006305502B2/en not_active Ceased
- 2006-06-09 ES ES06766266T patent/ES2354455T3/es active Active
-
2008
- 2008-04-09 ZA ZA2008/03118A patent/ZA200803118B/en unknown
- 2008-04-09 NO NO20081739A patent/NO341252B1/no not_active IP Right Cessation
- 2008-12-03 HK HK08113183.2A patent/HK1120424A1/xx not_active IP Right Cessation
-
2011
- 2011-01-20 CY CY20111100064T patent/CY1111560T1/el unknown
- 2011-01-20 HR HR20110041T patent/HRP20110041T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
AU2006305502B2 (en) | 2009-11-26 |
CN101291670B (zh) | 2012-07-04 |
AU2006305502A1 (en) | 2007-04-26 |
NZ567865A (en) | 2010-07-30 |
WO2007046111A1 (en) | 2007-04-26 |
CN101291670A (zh) | 2008-10-22 |
KR101125820B1 (ko) | 2012-03-28 |
RS51627B (en) | 2011-08-31 |
PL1948166T3 (pl) | 2011-04-29 |
EP1948166B1 (de) | 2010-10-20 |
ES2354455T3 (es) | 2011-03-15 |
SI1948166T1 (sl) | 2011-02-28 |
HRP20110041T1 (hr) | 2011-02-28 |
NO20081739L (no) | 2008-07-09 |
NO341252B1 (no) | 2017-09-25 |
US20100189646A1 (en) | 2010-07-29 |
EP1948166A1 (de) | 2008-07-30 |
US8143303B2 (en) | 2012-03-27 |
CA2626646A1 (en) | 2007-04-26 |
PT1948166E (pt) | 2011-01-19 |
CA2626646C (en) | 2011-03-01 |
DK1948166T3 (da) | 2011-01-31 |
EA200801114A1 (ru) | 2009-02-27 |
DE602006017722D1 (de) | 2010-12-02 |
ZA200803118B (en) | 2011-11-30 |
HK1120424A1 (en) | 2009-04-03 |
CY1111560T1 (el) | 2015-10-07 |
JP2009512681A (ja) | 2009-03-26 |
EA014694B1 (ru) | 2010-12-30 |
BRPI0619308A2 (pt) | 2013-03-05 |
KR20080064848A (ko) | 2008-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1888541T3 (da) | Benzo(d)isoxazol-3-yl-amin-forbindelser og anvendelse af disse som vanilloidreceptorligander | |
ATE427927T1 (de) | Phenylacetylenderivate mit affinitat zum mglur5- rezeptor | |
NO20075624L (no) | Nye histamin H3-reseptorligander og deres terapeutiske anvendelser | |
EA200801428A1 (ru) | Производные пиридиазинона для лечения опухолей | |
NO20080705L (no) | Aminoaryl Sulphonamide Derivatives as functional 5-HT6 Ligands | |
EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
ATE445593T1 (de) | Acetylenderivate | |
ATE466842T1 (de) | 3-substituierte pyridinderivate als h3- antagonisten | |
CR9822A (es) | Derivados de benzotiazol ciclobutil amina y su uso como ligandos de los receptores 3 de histamina | |
ATE467632T1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
NO20080553L (no) | Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander | |
WO2007021711A3 (en) | Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands | |
ATE513810T1 (de) | Aminoalkoxy-aryl-sulfonamidverbindungen und ihre verwendung als 5-ht6-liganden | |
ATE485040T1 (de) | Carbazol-derivate als funktionale 5-ht6-liganden | |
MX2009005242A (es) | Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo. | |
ATE486078T1 (de) | 5,6-disubstituierte oxadiazolopyrazine und thiadiazolopyrazine als liganden des cxc- chemokinrezeptors | |
IN2014DN04587A (de) | ||
TH95735A (th) | อนุพันธ์ 3-ซัลโฟนิลอินดาโซลที่ถูกแทนที่เป็นลิแกนด์ 5-ไฮดรอกซีทริปทามีน-6 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1948166 Country of ref document: EP |